Results 141 to 150 of about 36,105 (235)

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20‐Year Single‐Centre Experience

Contact Dermatitis, Volume 94, Issue 6, Page 677-688, June 2026.
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli, Khadija Mansour, Ghada Jaouahdou, Manel Ben Belgacem, Yosra Soua, Nadia Ben Fredj, Jameleddine Zili, Haifa Ben Romdhane, Karim Aouam   +8 more
wiley   +1 more source

Residual Pockets as an Endpoint on Periodontal Disease Progression in Supportive Periodontal Care

Journal of Clinical Periodontology, Volume 53, Issue 6, Page 947-955, June 2026.
ABSTRACT Aim To investigate whether the number of residual probing pocket depths (PPDs) ≥ 5 mm predicts periodontitis progression in non‐smoking patients undergoing supportive periodontal care (SPC). Materials and Methods This retrospective study included 121 patients (3028 teeth), with Stage III/IV, Grade B/C periodontitis, who completed active ...
John Rong Hao Tay, Ethan Ng, Dawn Shu Fen Siow, Stella Jinran Zhan, Seyed Ehsan Saffari, Rodrigo López, Philip M. Preshaw   +6 more
wiley   +1 more source

Evaluation of Neuropsychiatric Events in Patients Receiving Levetiracetam for Seizure Prophylaxis Following Traumatic Brain Injury. [PDF]

J Pharm Technol
Ammoscato MJ, Evers AN, Partington JR, Reinert JP.   +3 more
europepmc   +1 more source

Hydroxypropyl Methylcellulose Capsules Enhance Aerodynamic Performance of Carrier-Based Dry Powder Inhaler Formulations: A Comprehensive Evaluation of Capsule Material Effects. [PDF]

Pharmaceutics
Dumont C, Picco S, Noriega-Fernandes B, Verlhac P, Elena Cortez A, Boulet C, Gallagher M, Bock C, Jannin V.   +8 more
europepmc   +1 more source

Evaluation of neurotoxicity of drugs from morphological and electrophysiological endpoints using human iPSC-derived neural cell models. [PDF]

Front Cell Infect Microbiol
Qu Z, Li S, Qiu J, Huo G, Liu Y, Zhang D, Yang Y, Geng X, Lin Z.   +8 more
europepmc   +1 more source

Leveraging developmental neurotoxicity data in zebrafish embryos through the use of artificial intelligence methods. [PDF]

Front Toxicol
Heusinkveld HJ, Hessel EVS, Zwart EP, Gremmer ER, Pennings JLA.   +4 more
europepmc   +1 more source

Navigating a Dual Hyperinflammatory State: Overlap of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) and Secondary Hemophagocytic Lymphohistiocytosis (HLH) in a Child. [PDF]

Cureus
Gupta A, Prasad B, Dhumale A, Rajkumar K, Bhar VS, Gupta S.   +5 more
europepmc   +1 more source

Long-term effects of carbamazepine on bone-related biochemical markers in patients with epilepsy. [PDF]

Acta Epileptol
Hakami AY, Althagafi AA, Alkhayat AS, Alturkistani BA, Mawar HE, Ibrahim IH, Abualhamail H, Ahmed ME.   +7 more
europepmc   +1 more source

Antiseizure Treatments and Liver Injury: Expect (and Prevent) the Unexpected. [PDF]

Epilepsy Curr
Bunch M, Klocke S, Woodrich N, Barritt AS, Eyal S.   +4 more
europepmc   +1 more source

A Clinically Relevant Drug Interaction Between Busulfan and Rifampin in the Setting of Hematopoietic Stem Cell Transplant Conditioning. [PDF]

Pharmacol Res Perspect
Drangines C, Laquet J, Kunwor R.
europepmc   +1 more source